ScienceAstraZeneca files for U.S. FDA approval of HUTCHMED lung cancer drug combination
HUTCHMED said on Tuesday that AstraZeneca had applied to the U.S. Food and Drug Administration for approval of the ORPATHYS-TAGRISSO combination to treat patients with advanced lung cancer.
R
Reuters★★☆☆☆2026-09-29 05:25Original
AstraZeneca files for U.S. FDA approval of HUTCHMED lung cancer drug combination
Science